CTI BioPharma Corp (CTIC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3101 WESTERN AVENUE SEATTLE, WA 98121

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. The company concentrates its efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, the company has recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. The company's headquartered in Seattle, Washington.

Data as of 2021-05-08 10:36:14 -0400
Market Cap209.885 Million Shares Outstanding93.282 Million Avg 30-day Volume990.771 Thousand
P/E Ratio-4.59901 Dividend Yield EPS-0.682
Price/Sales Debt to Equity1.35 EBITDA-41.912 Million
Price to Book Value4.48 Forward PE-2.49 Enterprise Value158.131 Million
Total Cash57.412 Million Current Debt14.519 Million Gross Profit
BETA0.20689 52-week High/Low4.13 / 0.9629 Next Earnings Date2021-06-01 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CTIC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 63 38 65.79% 24 (1.44%) 15 (0.93%) 60.0%
13F shares: 43.692 Million 39.584 Million 10.38% 26.886 Million 24.105 Million 11.54%
% Ownership 57.892 53.6714 7.86% 35.6241 32.6844 8.99%
New Positions: 29 5 480.0% 10 2 400.0%
Increased Positions 12 10 20.0% 5 4 25.0%
Closed Positions 4 10 -60.0% 1 3 -66.67%
Reduced Positions 9 8 12.5% 4 2 100.0%
Total Calls 232.26 Thousand 250.618 Thousand -7.33% 76.7 Thousand 42.5 Thousand 80.47%
Total Puts 60.526 Thousand 52.151 Thousand 16.06%
PUT/CALL Ratio 0.26 0.21 23.81% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CTIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTIC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2 Million total shares from 6 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • 10% Owner
  • SEE REMARKSSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
2,153,239 2021-04-01 2

TUCKSON REED VAUGHN

  • Director
80,000 2021-03-10 1

PERRY MATTHEW D

  • Director
80,000 2021-03-10 1

METZGER MICHAEL A

  • Director
80,000 2021-03-10 1

PARKINSON DAVID ROSS

  • Director
80,000 2021-03-10 1

FISCHER LAURENT

  • Director
80,000 2021-03-10 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
7,520,600 2021-01-07 1

SEELEY BRUCE J. EVP, CHIEF OPERATING OFFICER

  • Officer
237,500 2020-07-01 2

CRAIG ADAM R PRESIDENT AND CEO

  • Officer
  • Director
805,000 2020-07-01 1

KIRSKE DAVID EVP, CHIEF FINANCIAL OFFICER

  • Officer
203,798 2020-07-01 1

BVF GP HOLDINGS LLC

BVF I GP LLC

BVF II GP LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
5,150,400 2020-03-02 0

TELLING FRED

  • Director
0 2018-09-18 0

SINGER JACK W EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-05-16 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
1,779,290 2018-02-08 2

LOVE RICHARD L

  • Director
73,718 2017-09-28 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ISALY SAMUEL D

  • 10% Owner
5,000,000 2017-06-13 0

NUDELMAN PHILLIP M PHD

  • Director
73,129 2017-04-29 0

PLUNKETT MATTHEW EVP, CHIEF BUSINESS OFFICER

  • Officer
  • Director
0 2017-03-01 0

BIANCO JAMES A

  • Director
0 2016-10-02 0

MUNDINGER MARY ONEIL

  • Director
360,019 2016-04-29 0

BIANCO LOUIS A EVP, FINANCE & ADMINISTRATION

  • Officer
622,970 2016-03-21 0

BAUER JOHN H

  • Director
0 2015-09-23 0

IGNAGNI KAREN

  • Director
0 2015-09-23 0

BAXTER HEALTHCARE SA

  • 10% Owner
No longer subject to file 2015-04-30 0

GREGORIAN VARTAN

  • Director
468,937 2014-03-28 0

BAXTER HEALTHCARE SA

BAXTER INTERNATIONAL INC

  • 10% Owner
15,673,981 2013-11-25 0

BENNER STEVEN E EVP, CHIEF MEDICAL OFFICER

  • Officer
396,705 2013-03-21 0

PHILIPS CRAIG

  • FORMER PRESIDENT
414 2012-11-19 0

ERAMIAN DANIEL G EVP, CORPORATE COMMUNICATIONS

  • Officer
354,350 2012-09-20 0

STROMATT SCOTT EVP,CLINICAL DEV & REG AFFAIR

  • Officer
No longer subject to file 2008-04-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 1,044,813 $2.50 a 4,085,933 direct -2.2901 -8.0153 0.0 1 -8.0153 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 17 $25,000.00 a 17 direct

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 5,171 $2.50 a 488,879 direct -2.2901 -8.0153 0.0 1 -8.0153 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 239 $25,000.00 a 239 direct

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 950,016 $2.50 a 3,059,296 direct -2.2901 -8.0153 0.0 1 -8.0153 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF I GP LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BVF II GP LLC SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner SEE EXPLANATION OF RESPONSES

LAMPERT MARK N - > 10% Owner SEE EXPLANATION OF RESPONSES

2021-04-05 20:15:27 -0400 2021-04-01 P 344 $25,000.00 a 344 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CTI BIOPHARMA CORP CTIC 2021-05-10 22:15:04 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 21:45:02 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 21:15:02 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 20:45:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 20:15:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 19:45:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 19:15:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 18:45:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 18:15:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 17:45:02 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 17:15:03 UTC -1.1719 1.2219 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 16:45:03 UTC -1.156 1.206 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 16:15:03 UTC -1.156 1.206 1900000
CTI BIOPHARMA CORP CTIC 2021-05-10 15:45:03 UTC -1.156 1.206 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 15:15:03 UTC -1.156 1.206 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 14:45:04 UTC -1.1135 1.1635 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 14:15:04 UTC -1.1135 1.1635 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 13:45:04 UTC -1.1135 1.1635 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 13:15:03 UTC -1.1135 1.1635 1500000
CTI BIOPHARMA CORP CTIC 2021-05-10 12:45:02 UTC -1.1135 1.1635 1400000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-04-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-04-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-05-07 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-28 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-05-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.47% 2015-06-03 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.5% 2015-06-15 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-07-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-07-31 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-08-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-08-07 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-10-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.51% 2015-10-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.23% 2015-11-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2015-11-26 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2015-12-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.88% 2015-12-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-01-12 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.02% 2016-02-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.99% 2016-02-25 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2016-03-18 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2016-03-30 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.22% 2016-05-03 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2016-05-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2016-06-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.96% 2016-07-26 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-08-16 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-08-29 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-09-09 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.78% 2016-12-05 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.82% 2017-01-05 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2017-01-09 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2017-01-11 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-23 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.08% 2017-01-24 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-27 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2017-02-14 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.73% 2017-06-06 Italy
D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.48% 2017-06-14 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.56% 2013-12-20 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.41% 2014-01-02 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.74% 2014-01-13 Italy
Jane Street Group, LLC CTI BIOPHARMA CORP 0.35% 2014-01-14 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.0% 2013-01-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.94% 2013-01-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-01-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-01-30 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-02-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-02-08 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-02-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.23% 2013-02-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.18% 2013-02-20 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.25% 2013-02-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.17% 2013-02-26 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2013-03-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.98% 2013-03-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.04% 2013-03-27 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.96% 2013-03-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-04-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.28% 2013-04-11 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.14% 2013-04-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.8% 2013-04-16 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-17 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.68% 2013-04-19 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.53% 2013-04-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.49% 2013-04-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.59% 2013-06-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.35% 2013-07-01 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.57% 2013-10-02 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.6% 2013-10-03 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-10-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.71% 2013-10-09 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.67% 2013-10-14 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.7% 2013-10-15 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.66% 2013-10-17 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-22 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.61% 2013-10-24 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-25 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.44% 2013-10-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2012-11-30 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.97% 2012-12-03 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.35% 2012-12-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.42% 2012-12-05 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-06 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.54% 2012-12-07 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-10 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.15% 2012-12-12 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.05% 2012-12-18 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.95% 2012-12-19 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.19% 2012-12-21 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.24% 2012-12-24 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.3% 2012-12-26 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.29% 2012-12-28 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.38% 2013-01-04 Italy
The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-01-09 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.5% 2015-06-29 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.48% 2015-08-17 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.52% 2017-02-07 Italy
Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.47% 2017-03-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-04-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2013-04-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2013-05-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-05-31 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-07-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-08-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2013-09-16 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-18 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-20 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-23 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.46% 2013-09-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.62% 2014-02-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-03-04 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.57% 2014-03-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.44% 2014-03-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2014-04-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.63% 2014-05-01 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2014-05-02 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.8% 2014-05-06 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.79% 2014-05-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-27 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-05-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-06-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-06-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-07-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-08-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-09-18 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-10-14 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-10-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-11-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-12 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-11-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-20 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-11-21 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-12-04 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-05 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-12-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.47% 2014-12-31 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2015-02-02 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-02-24 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.58% 2015-02-25 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2015-03-05 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.78% 2015-03-09 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.66% 2015-03-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2015-03-16 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.83% 2015-03-17 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.75% 2015-03-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2015-03-30 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.55% 2015-04-07 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-04-08 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2015-06-19 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-06-26 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2015-07-10 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2015-07-13 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2015-08-27 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-10-28 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2017-02-03 Italy
Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2017-05-22 Italy

Elevate your investments